Luo Peiqiong, Li Danpei, Guo Yaming, Meng Xiaoyu, Kan Ranran, Yu Xuefeng
Division of Endocrinology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan, 430030, Hubei, China.
Branch of National Clinical Research Center for Metabolic Diseases, Wuhan, 430030, Hubei, China.
Acta Diabetol. 2024 Dec 18. doi: 10.1007/s00592-024-02432-9.
To investigate the association between estimated glucose disposal rate (eGDR) and kidney function decline among populations with different glucose tolerance statuses including normal glucose tolerance (NGT), prediabetes, and diabetes.
The present study analyzed 5,069 participants from a cohort study. The association between eGDR and kidney function decline was assessed using binary logistic regression. Restricted cubic splines (RCS) analyses were also performed to investigate the dose-dependent associations.
During up to 5 years of follow-up, 116 (2.30%) individuals experienced kidney function decline. Binary logistic regression showed that an increased level of eGDR was associated with decreased risk of kidney function decline after full adjustment, in all participants (Q4 vs. Q1 HR 0.13, 95% CI 0.05-0.30, p = 0.001), prediabetes (Q4 vs. Q1HR 0.11, 95% CI 0.01-0.44, p = 0.007), and diabetes (Q4 vs. Q1 HR 0.06, 95% CI 0.00-0.37, p = 0.012), but not in those with NGT. RCS analyses suggested dose-dependent relationships of eGDR with the risk of kidney function decline in all participants (L-shaped curve) and those with prediabetes (inverted U-shaped curve) and diabetes (L-shaped curve).
The association between elevated baseline eGDR and reduced risk of kidney function decline was significant in participants with prediabetes and diabetes, but not in those with NGT. These dose-dependent associations may have important implications for the assessment of high-risk patients by healthcare professionals and may lead to the development of more tailored and effective prevention strategies.
研究估计葡萄糖处置率(eGDR)与不同糖耐量状态人群(包括正常糖耐量(NGT)、糖尿病前期和糖尿病)肾功能下降之间的关联。
本研究分析了一项队列研究中的5069名参与者。使用二元逻辑回归评估eGDR与肾功能下降之间的关联。还进行了受限立方样条(RCS)分析以研究剂量依赖关系。
在长达5年的随访期间,116名(2.30%)个体出现肾功能下降。二元逻辑回归显示,在完全调整后,eGDR水平升高与肾功能下降风险降低相关,在所有参与者中(四分位数4与四分位数1相比,HR 0.13,95%CI 0.05 - 0.30,p = 0.001)、糖尿病前期(四分位数4与四分位数1相比,HR 0.11,95%CI 0.01 - 0.44,p = 0.007)和糖尿病患者中(四分位数4与四分位数1相比,HR 0.06,95%CI 0.00 - 0.37,p = 0.012),但在NGT人群中并非如此。RCS分析表明,在所有参与者(L形曲线)、糖尿病前期患者(倒U形曲线)和糖尿病患者(L形曲线)中,eGDR与肾功能下降风险呈剂量依赖关系。
基线eGDR升高与肾功能下降风险降低之间的关联在糖尿病前期和糖尿病参与者中显著,但在NGT人群中不显著。这些剂量依赖关系可能对医疗保健专业人员评估高危患者具有重要意义,并可能导致制定更具针对性和有效的预防策略。